U.S. market Closed. Opens in 16 hours 57 minutes

ESLA | Estrella Immunopharma, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312022-06-302021-06-30
RevenueN/AN/AN/A
Cost of RevenueN/AN/AN/A
Gross ProfitN/AN/AN/A
Operating Expenses1.57M1.69M733.69K
Selling, General & Admin1.37M296.25K276.46K
Research & DevelopmentN/A1.39M457.23K
Other Operating Expenses-201.31K-70.15KN/A
Operating Income-1.57M-1.69M-733.69K
Other Expenses / Income654.07K1.42KN/A
Before Tax Income-915.46K-1.69M-733.69K
Income Tax Expenses80.65K-235.14K-206.30K
Net Income-996.10K-1.69M-733.69K
Interest ExpensesN/AN/AN/A
Basic Shares Outstanding5.76M5.85M35.20M
Diluted Shares Outstanding5.76M5.85M35.20M
EBITDA-1.57M-1.69M-733.69K
EBITDA Margin0.00%0.00%0.00%
EBIT-915.46K-1.92M-939.99K
EBIT Margin0.00%0.00%0.00%
Financial Year End2022-12-312022-06-302021-06-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙